• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Keratoconus approach is promising


Early results from a clinical study of a non-incisional procedure indicate the approach produces substantial corneal flattening and improves visual outcomes.

Peter S. Hersh, MD, reported these initial results at the 5th International Congress of Corneal Cross Linking for Keratoconus here.

"Keraflex KXL is a promising new technology to decrease the protruding cone of keratoconus and make the irregular corneal optics smoother," said Dr. Hersh, director, Cornea and Laser Eye Institute–Hersh Vision Group, Teaneck, NJ, and clinical professor of ophthalmology and chief, Cornea and Refractive Surgery, UMDNJ–New Jersey Medical School, Newark. "Our early experience shows improvements in the keratoconic cornea that we have not seen with past technologies.

The minimally invasive procedure flattens the cornea biomechanically without removing corneal tissue. ömer Faruk Yilmaz, MD, performed all the procedures at Beyoglu Eye Research and Training Center, Istanbul, Turkey.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.